Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline? (ALZ-OREX)
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Listed as NCT05629871, this NA trial focuses on Neuropathology and remains actively recruiting participants. Sponsored by Institut National de la Santé Et de la Recherche Médicale, France, it has been updated 7 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Nov 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Jun 2024 [monthly]
Not Yet Recruiting NA
▶ Show 2 earlier versions
-
Jan 2023 — Feb 2023 [monthly]
Not Yet Recruiting NA
-
Dec 2022 — Jan 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .